Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mineralys Therapeutics, Inc. (MLYS)
NASDAQ:MLYS
RESEARCH TOOLSreports
Mineralys Therapeutics, Inc. (MLYS) Ownership - Who Owns Mineralys Therapeutics, Inc.?
261 Followers
Mineralys Therapeutics, Inc. (MLYS) Ownership Overview
57.76% Insiders
6.94% Mutual Funds
5.66% Other Institutional Investors
29.65% Public Companies and
Individual Investors
The ownership structure of Mineralys Therapeutics, Inc. (MLYS) stock is a mix of institutional, retail and individual investors. Approximately 12.59% of the company’s stock is owned by Institutional Investors, 57.76% is owned by Insiders and 29.65% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 14, 2024 | Samsara Biocapital Gp, Llc >10% Owner | xxxxxxxxxxxxx | $7499993 |
| Nov 27, 2023 | Jon Congleton Ceo,director | xxxxxxxxxxxxx | $25330 |
| Sep 08, 2023 | Jon Congleton Ceo,director | xxxxxxxxxxxxx | $27180 |
| Aug 21, 2023 | Jon Congleton Ceo,director | xxxxxxxxxxxxx | $27225 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Mar 31, 2024 | xxxxxxxxxxxxx | $59799 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $2366364 | |
| Mar 31, 2024 | xxxxxxxxxxxxx | $62626203 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,850,984 | Institution | 9.77% | 65,100,205 | |
| 1,296,958 | Institution | 2.61% | 17,405,176 | |
| 1,170,889 | Institution | 2.36% | 15,713,330 | |
| 852,912 | Institution | 1.72% | 11,446,079 | |
| 622,059 | Institution | 1.25% | 8,348,032 | |
| 435,885 | Institution | 0.88% | 5,849,577 | |
| 280,824 | Institution | 0.57% | 3,768,658 | |
| 242,942 | Institution | 0.49% | 3,260,282 | |
| 208,557 | Institution | 0.42% | 2,798,835 | |
| 206,422 | Institution | 0.42% | 2,770,183 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 852,912 | Institution | 1.72% | 11,446,079 | |
| 622,059 | Institution | 1.25% | 8,348,032 | |
| 435,885 | Institution | 0.88% | 5,849,577 | |
| 280,824 | Institution | 0.57% | 3,768,658 | |
| 242,942 | Institution | 0.49% | 3,260,282 | |
| 208,557 | Institution | 0.42% | 2,798,835 | |
| 206,422 | Institution | 0.42% | 2,770,183 | |
| 163,942 | Institution | 0.33% | 2,200,102 | |
| 86,490 | Institution | 0.17% | 1,160,696 | |
| 55,096 | Institution | 0.11% | 739,388 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 756,264 | Institution | 1.52% | 10,149,063 | |
| 669,649 | Institution | 1.35% | 7,834,893 | |
| 371,819 | Institution | 0.75% | 4,350,282 | |
| 208,410 | Institution | 0.42% | 2,796,862 | |
| 148,606 | Institution | 0.30% | 1,994,293 | |
| 105,941 | Institution | 0.21% | 1,448,213 | |
| 106,305 | Institution | 0.21% | 1,243,769 | |
| 67,656 | Institution | 0.14% | 924,858 | |
| 64,255 | Institution | 0.13% | 862,302 | |
| 56,450 | Institution | 0.11% | 757,559 |
FAQ
Who Owns Mineralys Therapeutics, Inc. (MLYS)?
According to the latest TipRanks data, approximately 5.66% of the company's stock is held by institutional investors, 57.76% is held by insiders, and 29.65% is held by retail investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors?
According to the latest TipRanks data, approximately 5.66% of Mineralys Therapeutics, Inc. (MLYS) stock is held by institutional investors.
What percentage of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.65% of Mineralys Therapeutics, Inc. (MLYS) stock is held by retail investors.
Who owns the most shares of Mineralys Therapeutics, Inc. (MLYS)?
Peter Kolchinsky owns the most shares of Mineralys Therapeutics, Inc. (MLYS).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.